PTC
ISEE

Private Trust Company’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Private Trust Company’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13
Closed -$1K – 1269
2014
Q3 		$1K Hold
13
– – ﹤0.01% 1818
2014
Q2 		$1K Hold
13
– – ﹤0.01% 1834
2014
Q1 		$0 Buy
+13
New +$439 ﹤0.01% 1881

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Trust Company's ISEE Position: Q4 2014 in Review

Private Trust Company sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2014, closing a stake of 13 shares — an estimated $1K sold.

Private Trust Company first reported a position in ISEE in Q1 2014 and held it in 3 quarters. The position peaked at $1K in Q3 2014. 116 funds tracked by Wall St. Rank hold ISEE as of Q4 2014.

  • Private Trust Company reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2014 after selling out during the quarter.
  • Private Trust Company sold 13 IVERIC bio, Inc. Common Stock shares in Q4 2014, an estimated $1K.
  • Private Trust Company first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
  • Private Trust Company's IVERIC bio, Inc. Common Stock position peaked at $1K in Q3 2014.
  • 116 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2014.

Based on Private Trust Company's 13F filing for Q4 2014, filed 28 Jan 2015.